• Health Care M&A Deals, April 2 , 2021

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is... Read More »
  • SOC Telemed Acquires Access Physicians

    The national telehealth provider SOC Telemed has announced a new deal for Access Physicians valued at $194 million upfront with additional potential consideration based on performance. Access Physicians is an experienced multi-specialty acute inpatient telemedicine provider focused on cardiac care, inpatient hospital care, tele-neurology,... Read More »
  • Procaps Group Merges with Union Acquisition

    If you were looking for another SPAC deal this week, say no more. Procaps Group announced a reverse merger with Union Acquisition Corp. II (NASDAQ: LATN). Founded in 1977, Procaps is a leading integrated international healthcare and pharmaceutical company with a successful history of growth and diversification. Procaps is the largest... Read More »
  • Organon Hits the Ground Running

    Early in March 2020, Merck & Co., Inc. (NYSE: MRK) announced the spin-off of a new company focused on women’s health. The new company, Organon & Co., will have a portfolio of more than 60 trusted medicines that address an entire spectrum of conditions that women face. Organon is expected to have a global footprint with approximately... Read More »
  • SomaLogic Goes Public With SPAC

    They just don’t stop coming. Another private healthcare company has agreed to go public via SPAC in a $1.23 billion deal. SomaLogic is merging with CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company affiliated with Casdin Capital, LLC and Corvex Management LP. SomaLogic is a commercial-stage proteomics company with... Read More »
Health Care M&A Deals, April 2 , 2021

Health Care M&A Deals, April 2 , 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Procaps Group’s reverse merger with with Union Acquisition Corp. II (NASDAQ: LATN) valued at $1.128 billion. Founded in 1977 and based in Colombia, Procaps is a leading integrated international healthcare and pharmaceutical company with a successful history of growth and diversification. It is the largest pharmaceutical integral CDMO in... Read More »
Health Care M&A Deals, April 2 , 2021

Health Care M&A Deals, March 26 , 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. One of the largest deals last week was the acquisition of PatientPing by private equity-backed Appriss Health, a large care coordination platform based in Boston, Massachusetts. PatientPing has developed a platform that enables providers to collaborate on shared patients through a comprehensive suite of solutions and allows provider organizations, health... Read More »
Health Care M&A Deals, April 2 , 2021

Health Care M&A Deals, March 19, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Roche Holding AG’s acquisition of GenMark Diagnostics for $1.8 billion. GenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics and reduce the total cost-of-care. GenMark’s eSensor XT-8 and ePlex systems are designed to support a... Read More »
Health Care M&A Deals, April 2 , 2021

Health Care M&A Deals, March 12, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is DocGo’s reverse merger with Motion Acquisition Corp. (NASDAQ: MOTN), a special purpose acquisition company to create a publicly traded entity. DocGo, based in New York City, provides last-mile telehealth and integrated medical mobility services. Its medical mobility services offer on-demand service response and real-time... Read More »
The State of the Rehabilitation M&A Market

The State of the Rehabilitation M&A Market

Throughout 2020, there wasn’t much to write about in the Rehabilitation sector. The industry was under regulatory pressure from CMS in the beginning of 2020, and then Covid-19 came around, making things even more difficult. Social distancing guidelines hindered in-person appointments, and we imagine that the effects of surgery cancellations at hospitals trickled down into this sector as well. U.S. Physical Therapy, Inc. (NYSE: USPH), one of the largest rehabilitation providers, saw a 13.8% drop in net patient revenue in 2020 compared with 2019, for instance. However, It was more difficult to discern the effects in the M&A market. The sector barely breaks double-digit deal volume on a... Read More »
Health Care M&A Deals, April 2 , 2021

Health Care M&A Deals, March 5, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Amgen’s acquisition of Five Prime Therapeutics for $1.9 billion. Five Prime Therapeutics Five Prime Therapeutics is a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies. The company collaborates with leading global pharmaceutical companies and has therapies in... Read More »